Vir Biotechnology, Inc. (VIR) Ownership

$7.95

north_east
$0.45 (6%)
Day's range
$7.62
Day's range
$8.11

Vir Biotechnology, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
SB INVESTMENT ADVISERS (UK) LTD 02/14/2025 16.68 M $122.46 M   0.00% 12.21%
BLACKROCK FUNDING, INC. /DE 02/07/2025 16.46 M $120.84 M   0.53% 12.05%
VANGUARD GROUP INC 02/11/2025 13.13 M $96.38 M   -0.04% 9.61%
ORBIMED ADVISORS LLC 02/14/2025 3.22 M $23.62 M   -9.92% 2.36%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 2.20 M $16.13 M   0.36% 1.61%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 1.92 M $14.06 M   58.03% 1.40%
JPMORGAN CHASE & CO 02/12/2025 1.81 M $13.26 M   66.34% 1.32%
MILLENNIUM MANAGEMENT LLC 02/14/2025 1.72 M $12.59 M   55.25% 1.26%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 1.25 M $9.19 M   10.44% 0.92%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 1.24 M $9.08 M   4.68% 0.91%
BAKER BROS. ADVISORS LP 02/14/2025 1.08 M $7.96 M   100.00% 0.79%
SIO CAPITAL MANAGEMENT, LLC 02/14/2025 1.05 M $7.74 M   100.00% 0.77%
ARTISAN PARTNERS LIMITED PARTNERSHIP 02/12/2025 918,529 $6.74 M   100.00% 0.67%
IKARIAN CAPITAL, LLC 02/14/2025 897,862 $6.59 M   100.00% 0.66%
HUDSON BAY CAPITAL MANAGEMENT LP 02/14/2025 849,873 $6.24 M   60.89% 0.62%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 848,454 $6.23 M   16,169.49% 0.62%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 02/14/2025 769,725 $5.65 M   -21.08% 0.56%
IKARIAN CAPITAL, LLC 02/14/2025 720,300 $5.29 M   100.00% 0.53%
BANK OF NEW YORK MELLON CORP 02/04/2025 604,067 $4.43 M   -5.95% 0.44%
SPHERA FUNDS MANAGEMENT LTD. 02/14/2025 581,829 $4.27 M   523.42% 0.43%
GOLDMAN SACHS GROUP INC 02/11/2025 517,130 $3.80 M   -37.90% 0.38%
D. E. SHAW & CO., INC. 02/14/2025 502,000 $3.68 M   -46.06% 0.37%
02/05/2025 489,485 $3.59 M   100.00% 0.36%
PRINCIPAL FINANCIAL GROUP INC 01/31/2025 447,313 $3.28 M   3.69% 0.33%
WALLEYE CAPITAL LLC 02/13/2025 434,460 $3.19 M   1,727.30% 0.32%
INVESCO LTD. 02/13/2025 398,772 $2.93 M   0.65% 0.29%
ABRDN PLC 01/24/2025 363,161 $2.67 M   100.00% 0.27%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 359,572 $2.64 M   -31.10% 0.26%
EMPOWERED FUNDS, LLC 01/28/2025 290,626 $2.13 M   -11.87% 0.21%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 02/14/2025 263,243 $1.93 M   -20.18% 0.19%
BOOTHBAY FUND MANAGEMENT, LLC 02/14/2025 260,371 $1.91 M   100.00% 0.19%
CI PRIVATE WEALTH, LLC 02/10/2025 257,520 $1.89 M   -9.02% 0.19%
EXODUSPOINT CAPITAL MANAGEMENT, LP 02/12/2025 246,833 $1.81 M   100.00% 0.18%
TWO SIGMA INVESTMENTS, LP 02/14/2025 245,876 $1.80 M   -10.92% 0.18%
PRUDENTIAL FINANCIAL INC 02/11/2025 244,569 $1.80 M   -42.50% 0.18%
UBS GROUP AG 02/14/2025 240,113 $1.76 M   -37.34% 0.18%
RHUMBLINE ADVISERS 01/30/2025 236,681 $1.74 M   0.55% 0.17%
LEGAL & GENERAL GROUP PLC 02/13/2025 231,983 $1.70 M   -10.41% 0.17%
AMERICAN CENTURY COMPANIES INC 02/11/2025 230,724 $1.69 M   11.52% 0.17%
PUBLIC SECTOR PENSION INVESTMENT BOARD 02/14/2025 229,294 $1.68 M   18.07% 0.17%
BARCLAYS PLC 02/13/2025 221,178 $1.62 M   -59.80% 0.16%
AMERIPRISE FINANCIAL INC 02/14/2025 219,172 $1.61 M   -18.04% 0.16%
DEUTSCHE BANK AG\ 02/14/2025 216,734 $1.59 M   14.54% 0.16%
SQUAREPOINT OPS LLC 02/14/2025 214,263 $1.57 M   106.62% 0.16%
BOOTHBAY FUND MANAGEMENT, LLC 02/14/2025 207,700 $1.52 M   100.00% 0.15%
STATE OF ALASKA, DEPARTMENT OF REVENUE 01/27/2025 202,441 $1.49 M   32.97% 0.15%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 02/14/2025 201,185 $1.48 M   100.00% 0.15%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 02/14/2025 196,780 $1.44 M   3.75% 0.14%
CITIGROUP INC 02/12/2025 184,317 $1.35 M   61.09% 0.13%
UBS ASSET MANAGEMENT AMERICAS INC 02/14/2025 181,325 $1.33 M   29.18% 0.13%

Vir Biotechnology, Inc. institutional Ownership - FAQ's

During the previous two years, 256 institutional investors and hedge funds held shares of Vir Biotechnology, Inc.. The most heavily invested institutionals were:

SB INVESTMENT ADVISERS (UK) LTD: 16.68 M

BlackRock Funding, Inc. /DE: 16.46 M

VANGUARD GROUP INC: 13.13 M

ORBIMED ADVISORS LLC: 3.22 M

GEODE CAPITAL MANAGEMENT, LLC: 2.2 M

DIMENSIONAL FUND ADVISORS LP: 1.92 M

64.98% of Vir Biotechnology, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 102.49 M shares in the last 24 months. This purchase volume represents approximately $814.81 M in transactions.